Zim Laboratories (BOM:541400) Total Liabilities : ₹2,081 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Zim Laboratories Total Liabilities?

Zim Laboratories's Total Liabilities for the quarter that ended in Mar. 2024 was ₹2,081 Mil.

Zim Laboratories's quarterly Total Liabilities declined from Sep. 2023 (₹1,397.20 Mil) to Dec. 2023 (₹0.00 Mil) but then increased from Dec. 2023 (₹0.00 Mil) to Mar. 2024 (₹2,080.76 Mil).

Zim Laboratories's annual Total Liabilities declined from Mar. 2022 (₹1,659.19 Mil) to Mar. 2023 (₹1,412.33 Mil) but then increased from Mar. 2023 (₹1,412.33 Mil) to Mar. 2024 (₹2,080.76 Mil).

Zim Laboratories Total Liabilities Historical Data

The historical data trend for Zim Laboratories's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zim Laboratories Total Liabilities Chart

Zim Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

1,714.81

1,640.32

1,659.19

1,412.33

2,080.76

Zim Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,412.33	-	1,397.20	-	2,080.76

Zim Laboratories Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Zim Laboratories's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1594.252	+	(356.006	+	130.504
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,081

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	4468.223	-	2387.461
	=	2,081

Zim Laboratories's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1594.252	+	(356.006	+	130.504
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2,081

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	4468.223	-	2387.461
	=	2,081

Zim Laboratories Total Liabilities Related Terms

Thank you for viewing the detailed overview of Zim Laboratories's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Zim Laboratories (BOM:541400) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zim Laboratories Ltd (BOM:541400) » Definitions » Total Liabilities

Traded in Other Exchanges

ZIMLAB:India

Address

Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013

Website

https://www.zimlab.in

Zim Laboratories Ltd is a pharmaceutical company. It is mainly engaged in the manufacturing of formulation drugs and pre-formulation ingredients. Geographically, the group has a business presence in India and other countries, of which key revenue is derived from Outside India. The products offered by the company are Ondansetron, Tadalafil, Vitamin D3, Levocetirizine, Methylcobalamin, and others. The majority of its revenue gets derived from the sale of pharmaceutical goods.

Zim Laboratories (BOM:541400) Headlines

No Headlines